Log In
person
Guardant Health Inc
GH
summarize
2 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Precision Oncology |
Genetic, Genomic, and Sequencing Medical Diagnostic Services; Diversified Payors
These companies operate Genetic, Genomic, and Sequencing diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. Revenue is ultimately derived from commercial insurance providers, consumers as well as medicare and medicaid.
|
514.25M | 91.19% |
| Precision Oncology |
Contract Clinical Testing Services for Drug Manufacturers
These companies provide contract clinical testing services to pharmaceutical and biotechnology companies. These services can be employed anywhere from early-stage to late-stage drug development. In the process of providing these testing services, the companies gain approval from relevant regulatory agencies.
|
49.7M | 8.81% |
| keyboard_arrow_down |
Precision Oncology
Genetic, Genomic, and Sequencing Medical Diagnostic Services; Diversified Payors
|
514.25M | 91.19% |
| keyboard_arrow_right |
These companies operate Genetic, Genomic, and Sequencing diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. Revenue is ultimately derived from commercial insurance providers, consumers as well as medicare and medicaid.
|
||
| keyboard_arrow_down |
Precision Oncology
Contract Clinical Testing Services for Drug Manufacturers
|
49.7M | 8.81% |
| keyboard_arrow_right |
These companies provide contract clinical testing services to pharmaceutical and biotechnology companies. These services can be employed anywhere from early-stage to late-stage drug development. In the process of providing these testing services, the companies gain approval from relevant regulatory agencies.
|
||